Cognyte Software Ltd
NASDAQ:CGNT
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
7.8
11.39
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Cognyte Software Ltd
Cognyte Software Ltd. provides security analytics software that empowers governments and enterprises with actionable intelligence for a safer world. The main activity is focused on providing security and analytics software. The firm designs software that empowers governments and enterprises with Actionable Intelligence for solutions accelerate security investigations to successfully identify, neutralize, and prevent threats.
Cognyte Software Ltd. provides security analytics software that empowers governments and enterprises with actionable intelligence for a safer world. The main activity is focused on providing security and analytics software. The firm designs software that empowers governments and enterprises with Actionable Intelligence for solutions accelerate security investigations to successfully identify, neutralize, and prevent threats.
Revenue Growth: Cognyte reported Q3 revenue of $100.7 million, up 13.2% year-over-year, driven by strong demand for AI-powered investigative and Decision Intelligence solutions.
Profitability: Operating income and adjusted EBITDA both grew significantly faster than revenue, with adjusted EBITDA reaching $11.9 million, up 81.4% from last year.
Margin Expansion: Gross margin rose to 73.1%, up 297 basis points year-over-year, reflecting premium pricing and operational efficiencies.
Raised Guidance: Full-year revenue guidance was increased to $400 million (approx. 14% growth), with adjusted EBITDA outlook raised to $47 million (about 60% growth).
Strong Cash Position: Q3 cash flow from operations was $25 million, with $106.6 million in cash and no debt at quarter-end.
Healthy Backlog: Remaining performance obligations (RPO) stood at $576.6 million, supporting future revenue visibility.
US Market Progress: The company continues to expand in the US, with new partnerships such as LexisNexis and growing momentum across federal, state, and local agencies.
